AFR have a fair bit to answer for.. they are always first on the scene at the sniff of blood when it comes to MSB..
They were quite happy to join the conjecture and imply that MSB were about to fail FDA as a result of notes published
They only choose the headline for maximum clicks
Shorts clean up, retail gets rolled, just another day on the ASX
I bought mine at 1.80 so not too concerned but MSB should have been on the front foot and clarified the fact that FDA always seeks clarification prior to AdCom and then furthermore, prior to potential approval
The age of stem cells is upon us and FDA would be well advised to encourage investment into a company that pursues this field with a level of ethics and standards not often seen in the bio pharm world
Lets see how it plays out
MESO Nasdaq update, page-920
-
- There are more pages in this discussion • 4,830 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.030(3.06%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | 99.0¢ | $5.111M | 5.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 211966 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 136540 | 9 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |